Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and ...

The American Academy of Ophthalmology (AAO) kicked off their 2026 annual meeting today in New Orleans, with an authentic second-line parade of musicians, dancers and performers inviting conference ...

Experts at Fall Clinical Derm 2026 urge early JAK inhibitors over systemic steroids for atopic dermatitis and long-term vitiligo treatment, saying boxed-warning risks are overstated. It’s recommended ...

Large language models (LLMs) are now bringing new attention to the category, according to Art Papier, M.D., CEO of VisualDx. He also cautions that clinicians shouldn’t assume these tools are always ...

Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new ...

Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...

The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...

Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...

The lawsuit targets the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory model CMS finalized last week ...

Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...

The CEO and founder of a digital behavior company has advice for health plans considering asynchronous behavioral health ...